The Point of Care (PoC) molecular diagnostics market is forecasted to hit USD 5,295 Million by 2025. Then, it is likely to grow to USD 13,733.8 Million by 2035 with a CAGR of 10% over time. Things driving this growth include more people with long-term illnesses, bigger need for home tests, and the government backing …
Continue reading “Point-of-care Molecular Diagnostics Market to Hit USD 13.7B by 2035”